SCHEMBL4905352

SCHEMBL4905352

CCN(c1ccc(OCC(F)(F)C(F)F)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.41
HDAC8 Q9BY41 2/20 0.41
POLB P06746 1/20 0.39
HCRTR2 O43614 1/20 0.39
ESR1 P03372 1/20 0.39
PSEN1 P49768 2/20 0.38
PSEN2 P49810 2/20 0.38
APH1B Q8WW43 2/20 0.38
NCSTN Q92542 2/20 0.38
APH1A Q96BI3 2/20 0.38
PSENEN Q9NZ42 2/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894383 0.91 LMNA (0.44) NPSR1HDAC8POLBHCRTR2ESR1
SCHEMBL4902441 0.90 NPSR1 (0.43) NPSR1HDAC8POLBHCRTR2ESR1
SCHEMBL4905605 0.86 LMNA (0.42) NPSR1HDAC8POLBHCRTR2MAPT
SCHEMBL4904184 0.83 HCRTR2 (0.50) NPSR1HDAC8POLBHCRTR2ESR1
SCHEMBL4903639 0.83 HCRTR2 (0.50) NPSR1HDAC8POLBHCRTR2ESR1
SCHEMBL4906417 0.82 HDAC8 (0.52) NPSR1HDAC8POLBHCRTR2PSEN1
SCHEMBL4908889 0.82 LMNA (0.50) NPSR1POLBHCRTR2ESR1PSEN1
SCHEMBL4894413 0.82 MMP2 (0.49) NPSR1HDAC8POLBPSEN1PSEN2
SCHEMBL4898047 0.81 MAPT (0.47) NPSR1HDAC8POLBESR1MAPT
SCHEMBL4908025 0.81 MMP9 (0.42) NPSR1HDAC8ESR1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD NPSR1 773/4885HDAC8 959/4885POLB 1488/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPSR1 735/4885HDAC8 882/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.